VOMITING IS A POTENTIAL ADVERSE DRUG REACTION FOR LEVOMILNACIPRAN

Abstract

Levomilnacipran is a drug used to treat depression. Micro Labs is a generic drug company which had developed an extended release formulation of Levomilnacipran 120 mg capsule. Two studies were conducted to assess the safety, tolerability and bioequivalence of the extended release formulation of 120 mg Levomilnacipran capsules. A total of 42 subjects had been included for each of the fasting and fed studies. Out of them, 30 subjects completed the fasting study and 28 subjects completed the fed study. Pharmacokinetic parameters like Cmax, AUC0-t, AUC0-inf, Tmax, Kel, t1/2 and %AUCextra were calculated for Levomilnacipran in order to compare the bioavailability of the test and reference formulations. The studies were conducted in healthy human volunteers in both fasting and fed conditions as per the US regulatory requirements for conduct of bioequivalence studies. The formulations were found to be bioequivalent to each other. Vomiting was observed as a major adverse reaction.

Authors and Affiliations

Atreyee Sarkar, Shivanand Dhanure

Keywords

Related Articles

A META-ANALYSIS STUDY OF POLYCHEMOTHERAPY VERSUS MONOCHEMOTHERAPY IN PATIENTS OF METASTATIC BREAST CANCER

Polychemotherapy and intermittent monochemotherapy regimens in metastatic breast cancer were examined in a meta analysis that included both tumor response rate and toxicities. Randomized controlled studies (conducted dur...

EFFECT OF AQUEOUS EXTRACT OF CRYPTOLEPIS SANGUINOLENTA ON PHARMACOKINETICS OF ARTESUNATE

The aim of this study is to investigate the effect of aqueous extract of Cryptolepis sanguinolenta on the pharmacokinetics of the antimalarial; artesumate in male Sprague-Dawley rats. Reconstituted freeze dried Cryptolep...

RENAL VASCULARISATION CAUSING END - STAGE FAILURES AND OUTCOMES: A POOLED ANALYSIS OF COMMUNITY BASED STUDIES

Although acute renal failure (ARF) is believed to be common in the setting of critical illness and is associated with a high risk of death, little is known about its epidemiology and outcome or how these vary in differen...

SOLUBILITY ENHANCEMENT OF ARIPIPRAZOLE BY SOLID-SELF EMULSIFYING DRUG DELIVERY SYSTEMS

Self-emulsifying drug delivery systems are a promising approach for the formulation of drug compounds with poor aqueous solubility. The main objective of this work was to formulate liquid and solid-self emulsifying drug...

Photooxidized Vespa orientalis venom Improves Memory and Learning Activities in Rats

The work was aimed to study the effect of photooxidized Vespa orientalis venom on memory and learning activity on rats in presence of scopolamine and ondansetron using T maze, Elevated plus maze and passive avoidance. UV...

Download PDF file
  • EP ID EP618309
  • DOI 10.25004/IJPSDR.2017.090504
  • Views 76
  • Downloads 0

How To Cite

Atreyee Sarkar, Shivanand Dhanure (2017). VOMITING IS A POTENTIAL ADVERSE DRUG REACTION FOR LEVOMILNACIPRAN. International Journal of Pharmaceutical Sciences and Drug Research, 9(5), 224-227. https://europub.co.uk/articles/-A-618309